Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
McKesson
Medtronic
McKinsey
Baxter

Last Updated: January 27, 2023

CLINICAL TRIALS PROFILE FOR TOVIAZ


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Toviaz

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00605319 ↗ An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Completed Pfizer Phase 4 2010-01-01 The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.
NCT00605319 ↗ An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia Completed Weill Medical College of Cornell University Phase 4 2010-01-01 The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.
NCT00691093 ↗ Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous Therapy Completed Pfizer 2008-07-01 This is a observational study in patients treated with fesoterodine (Toviaz), who have failed on previous treatment for overactive bladder. It will collect epidemiological data and investigate the efficacy and tolerability of fesoterodine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Toviaz

Condition Name

Condition Name for Toviaz
Intervention Trials
Overactive Bladder 10
Urinary Bladder, Overactive 5
Urinary Incontinence 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Toviaz
Intervention Trials
Urinary Bladder, Overactive 20
Urinary Incontinence 4
Enuresis 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Toviaz

Trials by Country

Trials by Country for Toviaz
Location Trials
United States 75
Canada 12
Korea, Republic of 6
United Kingdom 5
Spain 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Toviaz
Location Trials
Connecticut 3
New York 3
Pennsylvania 3
North Carolina 3
Missouri 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Toviaz

Clinical Trial Phase

Clinical Trial Phase for Toviaz
Clinical Trial Phase Trials
Phase 4 7
Phase 3 3
Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Toviaz
Clinical Trial Phase Trials
Completed 20
Terminated 2
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Toviaz

Sponsor Name

Sponsor Name for Toviaz
Sponsor Trials
Pfizer 19
Stéphane Bolduc 2
University of North Carolina, Chapel Hill 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Toviaz
Sponsor Trials
Industry 20
Other 17
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Express Scripts
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.